Bayer introduces Saridon® Woman, India’s first ever solution addressing period pain woes

Saridon® Woman marks a significant breakthrough in the OTC sector, offering a unique solution for menstrual discomfort combining the efficacy of Paracetamol with plant-based molecule Hyoscine Butylbromide. It acts fast and offers long lasting relief with dual mode of action. This formulation is recommended by well-known global gynecologists’ association Royal College of Obstetricians and Gynaecologists.

As per a survey by the European Research Journal, 81% - 93% of women experience severe spasms & discomfort during their periods and a total of 63% of young women experience social withdrawal due to period pain making this launch extremely welcome. The launch reaffirms Bayer's dedication to enhancing women's health with innovative solutions.

Sandeep Verma, Country Head of Bayer Consumer Health India, emphasized, “With over 50 years of trusted efficacy in headache relief, Saridon® has been a trusted household name for Indians. Today, we proudly unveil Saridon® Woman—a true industry disruptor addressing monthly pains. Over the years women have found ways to deal with monthly pains – hot water bags, massages etc. However, today’s competitive environment where women are equal participants, Saridon® Woman offers quick and longer lasting relief as they go about achieving their daily or life goals. Saridon® Woman empowers women to prioritize their well-being with a self-care solution. This launch underscores our unwavering commitment to women's health.” 

Dr. Rashmi Yogish, MS(OBG), FRM, FRCRS, renowned gynecologist added, “In my practice, I frequently encounter women struggling with monthly pains and searching for effective relief. Many existing solutions fall short in terms of efficacy, longevity, and duration. There is a clear need for a period pain relief product that harmonizes the benefits of nature and scientific advancements, providing a reliable and enduring solution that allows women to continue their daily lives without disruption.”

Saridon® Woman represents Bayer’s commitment to advancing women’s health and wellness with its innovative formulation expertly designed for monthly pain relief. This milestone reflects Bayer's commitment to empowering women through accessible healthcare solutions, promising to redefine discussions on menstrual health and prioritize women's overall well-being.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to www.bayer.com.

Contact for media inquiries:

Nikita Senava,
Lintas Live, A Division of MullenLowe Lintas Group
Contact: +91 9768560098 | Email: Nikita.senava@lintaslive.in

Melissa Serrao,   
Bayer CropScience Limited Channels & Amplification
Contact: +91 982 0682163 | E-mail: melissa.serrao@bayer.com